California takes a bold step toward PBM reform. Governor Gavin Newsom has signed Senate Bill 41 (SB 41) into law, ushering in the state’s most comprehensive framework yet for Pharmacy Benefit Manager (PBM) oversight. The law mandates PBM licensing, bans spread pricing, enforces

PBM pressures. White-bagging mandates. 340B litigation. These challenges aren’t slowing down and neither should your compliance strategy. Following his presentation at NASP 2025, Frier Levitt Partner Jesse Dresser shares key legal insights for health system and specialty

As demand for GLP-1s like semaglutide and tirzepatide continues to surge, 503B outsourcing facilities are exploring a return to compounding these drugs, raising new legal, regulatory, and compliance challenges. In this article, Jesse Dresser and Edgar Asebey break down: ⚖️ The

Frier Levitt Achieves Full PBM Audit Reversal Frier Levitt recently secured a 100% reversal of PBM audit findings against a Virginia physician dispensing practice. The audit centered on Venclexta dispensing, but our team proved the practice followed manufacturer guidelines with

🚨 Speaker Spotlight Frier Levitt partners Jonathan Levitt, Jesse Dresser and Arielle Miliambro recently spoke at the Association for Value Based Cancer Care (AVBCC) Annual Summit 2025 in New York! Their sessions explored how hospital systems can audit PBMs and PBM-owned

New Jersey’s Louisa Carman Medical Debt Relief Act is now in effect, reshaping how medical debt can be billed, collected, and reported. • No more credit reporting for medical debt on or after July 22, 2024 • 120-day waiting period before any collections can begin • Interest

We’ve moved! Frier Levitt’s New York office is now located at One World Trade Center, a world-class home for our growing Healthcare & Life Sciences law practice. 📍 One World Trade Center, 45th Floor, New York, NY 10007 #FrierLevitt #OneWorldTradeCenter #HealthcareLaw

Cybersecurity is officially a False Claims Act issue. The DOJ’s Civil Cyber-Fraud Initiative makes it clear: incomplete cybersecurity certifications can carry the same legal risk as any other false claim—no breach required. In his new article, Christopher Furlong unpacks three

Are GER payment adjustments eating into your value-based care revenue? PBMs are increasingly passing Generic Effective Rate (GER) true-ups downstream to full-risk providers, often without transparency or clear contractual authority. These hidden deductions can quietly drain

Last chance to register! If you work with PBMs, you know how costly compliance mistakes can be. Join Partners Harini Bupathi & Eric P. Knowles for a live webinar with real-time Q&A on staying compliant and protecting your PBM participation. 🔗 Register: bit.ly/4nQvtmo

Pennsylvania pharmacies are facing costly Medicaid MCO recoupments tied to short-fills. Learn how to stay compliant with documentation and prescriber consent. 🔗 frierlevitt.com/articles/short… #PharmacyLaw #PBMAudit #MedicaidCompliance #FrierLevitt #HealthcareLaw #PharmacyCompliance

Are DIR fees and below-cost PBM reimbursements putting your infusion pharmacy underwater? In their new article, Frier Levitt attorneys Jesse Dresser and Payal Amin, PharmD, RPh, Esq. explain how these practices distort true performance and outline practical steps pharmacies can

What’s shaping community pharmacies in 2025? At NCPA, the top themes were clear: 🔹 Reimbursement strain 🔹 Escalating PBM audits 🔹 Heightened board of pharmacy scrutiny Independent pharmacies remain resilient, but the compliance and contracting landscape is tougher than

Pharmacies are seeing more overlap between Board of Pharmacy inspections and PBM audits, increasing compliance risk heading into 2026. Join Eric P. Knowles of #FrierLevitt for a live webinar on how to stay compliant, prevent terminations, and protect your PBM participation. 🔗

What risks should pharmacies be preparing for as PBM audits and year-end network reviews continue to intensify? In our webinar, “Navigating the Pathway to Maintaining PBM Network Compliance,” Partners Harini Bupathi and Eric Knowles discussed the trends driving year-end PBM

Frier Levitt is proud to be recognized in the Chambers and Partners USA New York 2026 Spotlight Guide for Healthcare Law. This designation reflects our team’s dedication to supporting providers, pharmacies, life sciences companies, and healthcare organizations navigating complex

PBM audits and Board of Pharmacy oversight continue to create significant challenges for pharmacies, and understanding where these risks intersect is critical. Partners Harini Bupathi and Eric Knowles break down the most common pitfalls pharmacies face today, how to challenge

Are you struggling with PBM audit pressure, unclear documentation requirements, or shifting network rules? You’re not alone. During our recent webinar, “Navigating the Pathway to Maintaining PBM Network Compliance,” pharmacies across the country raised questions that reflect the

Manufacturer “exclusion lists” are blocking pharmacies from key controlled substances — often with little warning. In our latest article, Benjamin Youssef and Jesse Dresser break down why these exclusions happen, what triggers them, and the steps pharmacies must take to restore

New Jersey pharmacies are facing heightened PBM scrutiny heading into 2026. Our on-demand webinar, led by Frier Levitt attorneys Harini Bupathi, Esq. and Benjamin S. Youssef, Pharm.D., Esq. discusses the top audit risks and the steps pharmacies must take now to strengthen